Chromovitrectomy

Reading File
Finding Sources
Finding Sources
Searching PubMed

chromovitrectomy vital dyes vitreoretinal surgery

Finding Sources
Finding Sources
Searching PubMed

chromovitrectomy dyes ILM vitreous staining

Finding Sources
Finding Sources
Searching PubMed

chromovitrectomy AND vitreoretinal

Reading Article

PMID: 33252365

Reading Article

PMID: 26502062

Reading Article

PMID: 39566564

Finding Sources
Reading Article

PMID: 30395665

Reading Article

PMID: 25279128

I now have enough comprehensive information to write a detailed, well-sourced answer on chromovitrectomy.

Chromovitrectomy

Definition and Concept

Chromovitrectomy refers to the intraoperative use of vital dyes (chromophore-containing molecules that selectively stain living tissues) during vitreoretinal surgery to improve visualization of normally transparent or near-transparent posterior segment structures. The term combines "chromo" (color/dye) with "vitrectomy" (surgical removal of vitreous).
The primary targets for staining are:
  1. Posterior hyaloid face (vitreous cortex)
  2. Epiretinal membranes (ERM)
  3. Internal limiting membrane (ILM)
Without dye assistance, these thin, optically clear membranes are extremely difficult to distinguish from the underlying retina, making complete and safe removal challenging. Chromovitrectomy was introduced around 2000 to reduce complications from inadvertent incomplete membrane removal and retinal trauma.

Why Chromovitrectomy Matters

StructureWhy it is hard to seeConsequence of missed removal
Posterior hyaloidThin, gel-like, nearly transparentIncomplete vitreous detachment, vitreoretinal traction
Epiretinal membraneThin fibrocellular sheet on retinaResidual traction, visual distortion, macular pucker recurrence
ILM0.1 micron thick basement membrane of Muller cellsRetained ILM causes recurrent macular holes or ERM regrowth

Vital Dyes Used in Chromovitrectomy

1. Indocyanine Green (ICG)

  • First dye used in chromovitrectomy (Kadonosono et al., 2000)
  • Selectively stains the ILM (bright green color)
  • ICG binds strongly to collagen type IV in the ILM
  • Concerns: Significant retinal toxicity - causes retinal pigment epithelium (RPE) damage, increased apoptosis of ganglion cells, visual field defects. Toxicity related to osmolarity, light exposure, concentration, and prolonged contact time
  • Most surgeons have now moved away from ICG due to its toxicity profile

2. Brilliant Blue G (BBG) - the current preferred ILM dye

  • Approved for clinical use in many countries (marketed as Membrane Blue-Dual and ILM Blue)
  • Selectively stains the ILM with high affinity (blue color)
  • Significantly lower toxicity profile than ICG
  • Reduces apoptosis compared to ICG
  • Preferred dye for ILM peeling in macular hole surgery, macular pucker, and vitreomacular traction syndrome
  • Recent safety concern (2025 systematic review, PMID 39566564): Phototoxicity has been reported with BBG and trypan blue; characteristic finding is macular pigmentary change with hypo- and hyper-autofluorescence, often sparing the fovea. Risk factors include prolonged surgery and repeat staining.

3. Trypan Blue (TB)

  • FDA-approved for ERM removal
  • Primarily stains epiretinal membranes (blue color); stains ILM less selectively than BBG
  • Also stains the anterior lens capsule (used in cataract surgery as well)
  • Lower ILM affinity compared to BBG - can be used for ERM visualization but may stain both ERM and ILM
  • Toxicity: Generally considered safe at standard concentrations; phototoxicity risk at higher concentrations (see PMID 39566564)

4. Triamcinolone Acetonide (TA)

  • A corticosteroid, not a traditional "dye" but functions as a vitreous stain
  • Crystalline particles deposit on the vitreous cortex/posterior hyaloid, making it visible as white flakes
  • FDA-approved (preservative-free formulation) for intraocular use
  • Most useful for: visualizing the posterior hyaloid, confirming posterior vitreous detachment (PVD) induction, and checking for residual vitreous on the retinal surface
  • No significant retinal toxicity at standard doses; IOP elevation is a known complication

5. Infracyanine Green (IFCG)

  • An analogue of ICG dissolved in 5% glucose rather than water (adjusts osmolarity)
  • Better osmotic compatibility with vitreous; less toxic than original ICG
  • Still has some phototoxicity concerns

6. Sodium Fluorescein

  • Used less commonly; stains the vitreous and posterior hyaloid
  • Requires blue-light illumination (fluorescence)
  • Concerns about toxicity limit widespread use

7. Patent Blue (PB)

  • Stains ERM and ILM
  • Less selective than BBG for ILM; used in some European centers
  • Relatively low toxicity profile

8. Newer/Experimental Agents

  • Lutein and anthocyanin from açaí fruit: natural dyes explored as potentially biocompatible alternatives
  • Dye-stained perfluorocarbon liquids (PFCL): A recent application - adding dye to PFCL to enhance visualization of these intraoperative tools during complex retinal surgery

Summary of Dye-Tissue Selectivity

DyeVitreous / Posterior HyaloidERMILMFDA Status
Triamcinolone acetonide+++--Approved (intraocular)
Trypan blue+++++Approved (ERM)
Brilliant Blue G-++++Approved in many countries
ICG-++++Off-label; largely abandoned
Patent blue-++++Off-label
Sodium fluorescein++--Off-label

Clinical Indications

  1. Macular hole surgery - ILM peeling (BBG preferred)
  2. Epiretinal membrane peeling - ERM identification (trypan blue or BBG)
  3. Diabetic tractional retinal detachment - vitreous base shaving, ERM/ILM dissection
  4. Vitreomacular traction syndrome - posterior hyaloid and ILM identification
  5. Pediatric vitrectomy - in very young eyes where PVD induction is difficult; TA for vitreous visualization
  6. Proliferative vitreoretinopathy (PVR) - complex ERM/ILM removal
  7. Giant retinal tears and complex retinal detachment - with PFCL staining

Injection Technique - Key Points

To minimize toxicity, the following technique guidelines are followed:
  • Slow injection of dye into the vitreous cavity
  • Keep injection away from the retinal surface (inject mid-vitreous or just above surface)
  • Protect the macular hole when injecting - avoid direct contact with exposed retinal pigment epithelium
  • Allow brief contact time, then wash out with balanced salt solution (BSS)
  • Use the lowest effective concentration
  • Avoid repeat staining (increases phototoxicity risk)
  • Use air-assisted technique: fill the eye with air first, then apply dye in an air-fluid interface for more targeted staining (reduces spread, increases concentration at the target)

Complications and Toxicity

ComplicationDyeMechanism
Retinal apoptosis / ganglion cell lossICGOsmotic injury, light-activated toxicity, detergent effect
Visual field defectsICGGanglion cell/NFL damage
RPE damageICG, BBG (high dose)Direct cellular toxicity
Phototoxicity (macular pigmentary change)BBG, Trypan bluePhotosensitization by dye chromophore
Elevated IOPTriamcinoloneSteroid-induced trabecular dysfunction
Cataract formationTriamcinolonePosterior subcapsular opacity
Endophthalmitis riskAny dyeContamination if non-sterile preparations used

The "Ideal" Chromovitrectomy Dye

The ideal vital dye for chromovitrectomy would have:
  • High selectivity for the target tissue (ILM, ERM, or vitreous)
  • Intense visible color for easy identification
  • No retinal toxicity (cellular, mitochondrial, or phototoxic)
  • Rapid washout from the eye
  • No systemic toxicity following intraocular injection
  • Stable shelf life, easy to prepare and use
As of current evidence, no single dye meets all criteria. Brilliant Blue G comes closest for ILM staining, and trypan blue for ERM, but both carry phototoxicity risk with prolonged use (PMID 39566564).

Evidence Base (Key References)

  • Bergamo VC et al. "Role of Vital Dyes in Chromovitrectomy." Asia Pac J Ophthalmol. 2020. [PMID 33252365]
  • Farah ME et al. "The Use of Vital Dyes during Vitreoretinal Surgery - Chromovitrectomy." Dev Ophthalmol. 2016. [PMID 26502062]
  • Bracha P, Ciulla TA, Baumal CR. "Vital Dyes in Vitreomacular Surgery." Ophthalmic Surg Lasers Imaging Retina. 2018. [PMID 30395665]
  • Hernandez F et al. "Chromovitrectomy: an update." J Ophthalmic Vis Res. 2014. [PMID 25279128] (free PMC text)
  • Neffendorf JE, Jackson TL. "Presumed phototoxicity from macular vital staining with BBG and Trypan Blue." Surv Ophthalmol. 2025. [PMID 39566564] (most recent systematic review - phototoxicity signal)

Bottom line: Chromovitrectomy has significantly improved the safety and completeness of vitreoretinal surgery by making transparent intraocular membranes visible. Brilliant Blue G is currently the most widely used and best-tolerated ILM dye; triamcinolone acetonide remains the standard for vitreous visualization; and trypan blue is preferred for ERM staining. The search for a truly non-toxic, highly selective dye continues, with natural compounds under active investigation.

Wide angle viewing vitrectomy

Reading File
Finding Sources
Finding Sources
Searching PubMed

wide angle viewing system vitreoretinal surgery

Finding Sources
Finding Sources
Reading Article

PMID: 27980854

Reading Article

PMID: 25196756

Finding Sources
Reading Article

PMID: 34403213

Searching PubMed

BIOM non-contact wide angle viewing vitrectomy comparison contact lens

Searching PubMed

wide angle viewing vitrectomy BIOM ROLS chandelier illumination

Finding Sources
Searching PubMed

non-contact wide angle viewing system retinal surgery outcomes

Finding Sources
Reading File
Reading Article

PMID: 37394991

Reading Article

PMID: 32409294

Reading File
Reading Article

PMID: 38454850

Reading File
I now have all the key information needed. Let me compose a comprehensive, well-structured answer.

Wide-Angle Viewing Systems in Vitrectomy

Concept and Rationale

Conventional vitrectomy was originally performed using a contact fundus lens on the microscope, which provided a limited, magnified view of the posterior pole. As vitreoretinal surgery expanded to treat peripheral pathology - retinal detachments, tears near the vitreous base, proliferative diabetic retinopathy, and peripheral fibrovascular membranes - the need for a panoramic view extending to the ora serrata became apparent.
Wide-angle viewing systems (WAVS) were developed to meet this need. They provide a panoramic view of the retina within a single field, allowing the surgeon to work peripherally without repeatedly rotating the eye or changing lenses.

Optical Principle

Wide-angle viewing systems consist of:
  1. An indirect condensing lens positioned beneath the operating microscope (replacing or augmenting the microscope's standard optic)
  2. An incorporated series of prisms to reinvert the image (since an indirect lens creates an inverted, laterally reversed image, like indirect ophthalmoscopy)
  3. The field of view can extend almost to the ora serrata
The image produced is thus reinverted by the prism system so the surgeon sees an upright, anatomically correct representation on the video monitor or through the microscope oculars.
  • Kanski's Clinical Ophthalmology, p. 708

Classification: Contact vs. Non-Contact

Contact Wide-Angle Viewing Systems

  • The lens is directly applied to the cornea (with coupling fluid - viscoelastic or BSS)
  • Examples: ACCES (Advanced Contact Curved Element System), Volk HM-Retina, AVI (Advanced Vitreous Instrument) contact lenses
  • The corneal surface aberration and reflection are cancelled because the lens directly applanates the cornea
  • Results in better image resolution and contrast of the fundus
  • Disadvantage: the eye position must remain fixed; rotating the eye disrupts contact and degrades the image
  • An assistant may be needed to hold the lens in place (reducing bimanual freedom)

Non-Contact Wide-Angle Viewing Systems

  • The lens is mounted on the microscope arm or head and floats above the cornea without touching it
  • Most widely used systems include BIOM (Binocular Indirect Ophthalmo Microscope) and ROLS (Retinal Observation Lens System)
  • Corneal surface must be kept moist with viscoelastic to prevent dehydration; condensation on the front lens can also impair visibility
  • Advantages:
    • Surgeon-independent (no assistant needed to hold the lens)
    • Eye can be freely rotated to examine peripheral retina
    • More flexible surgical maneuvers are possible
    • Compatible with true bimanual surgery using chandelier illumination
  • Disadvantage: slightly lower image resolution compared to contact systems

Key Comparison

FeatureContactNon-Contact
Image resolutionHigherSlightly lower
Assistant requiredOften yesNo
Eye rotationLimitedFreely allowed
Corneal hydration neededLess criticalCritical (dehydration degrades view)
SetupRequires coupling fluidMounted on scope arm
ExamplesACCES, AVIBIOM, ROLS

Field of View

System/LensApproximate Field of View
Standard contact vitrectomy lens (60D equivalent)~40-50 degrees
Wide-angle contact system~100-120 degrees
Non-contact BIOM~110-130 degrees
Ultra-wide field bubble system~128-148 degrees
Macular surgery lens (high magnification)~30-40 degrees (smaller field, more detail)
For most wide-angle systems, when the pupil diameter is 6 mm, the field of view approaches ~128-148 degrees (PMID 34403213).
Separate higher-magnification, smaller field lenses are available for macular surgery (macular holes, ERM peeling) where fine detail is more important than peripheral coverage.

Role of Chandelier Illumination with Wide-Angle Systems

Wide-angle viewing becomes most powerful when combined with chandelier (self-retaining) endoillumination:
  • Chandelier probes are small-gauge (25G or 27G), trocar-based, self-retaining light sources inserted through a separate sclerotomy
  • They provide diffuse wide-angle illumination of the vitreous cavity without the surgeon holding a light pipe
  • This frees both hands for true bimanual surgery - simultaneously manipulating two instruments (e.g., forceps + scissors, pick + cutter)
  • Particularly useful in:
    • Complex tractional retinal detachment (bimanual membrane delamination)
    • Giant retinal tear manipulation
    • Chandelier-assisted scleral buckling (see below)
    • Pediatric vitrectomy
  • Dual chandelier probes eliminate shadowing artifacts from a single light source
From Kanski's: "Wide-angle lighting and self-retaining chandelier sources... offer the advantages of freeing both of the surgeon's hands to carry out true bimanual surgery (which can be particularly useful in challenging cases) and of reducing phototoxicity (by increasing the working distance of the light probe from the retina)."

Chandelier-Assisted Scleral Buckling

One notable application of chandelier + non-contact WAVS is chandelier-assisted scleral buckling (CASB) - performing scleral buckling surgery (an external procedure) while using chandelier illumination and a wide-angle non-contact viewing system instead of an indirect ophthalmoscope.
  • Advantages: Panoramic view without head positioning, comfortable for the surgeon, can detect breaks more reliably
  • Outcomes: Anatomic success rates and visual outcomes are comparable between contact and non-contact WAVS for CASB (PMID 38454850, multicenter 2024 study: 85% vs 77% reattachment, p=0.34)
  • Both systems are valid choices; surgeon preference guides selection

Clinical Indications Where Wide-Angle Viewing is Particularly Valuable

  1. Rhegmatogenous retinal detachment - peripheral break detection, ensuring complete vitreous base shaving
  2. Proliferative diabetic retinopathy - peripheral fibrovascular membrane dissection, panretinal photocoagulation delivery
  3. Giant retinal tears - manipulation of large tears requires constant peripheral visualization
  4. Pediatric vitrectomy - small eyes with poor dilation; wide-angle essential for vitreous base work
  5. Penetrating trauma - peripheral vitreous base dissection, foreign body localization
  6. PVR (proliferative vitreoretinopathy) - circumferential membrane dissection
  7. Scleral buckling with chandelier - modern minimally invasive buckling

Limitations and Practical Considerations

IssueDetail
Peripheral view with small pupilsReduced; dilation is important for all systems
Corneal opacityContact systems handle it better (eliminates corneal interface); non-contact systems degrade significantly
Multifocal/toric IOLWAVS can still provide good views; contact systems preferred
Condensation (non-contact lens)Anti-fog maneuvers needed: warming the scope, wiping the lens
Magnification tradeoffWide field = lower magnification - must switch to macular lens for fine ILM work
A key practical point from the literature (PMID 25196756): "Surgeons can easily observe the fundus in almost the whole area and evaluate the retinal pathologies through the panoramic view even in eyes with small pupils, corneal opacity, or eyes implanted with multifocal intraocular lens or toric intraocular lens."

Clinical Outcomes Evidence

  • A large multicenter study (PRO Study, n=2256 eyes, PMID 32409294) comparing contact vs. non-contact WAVS for primary retinal detachment repair found no statistically significant difference in single surgery anatomic success (p=0.72) or final anatomic success (p=0.40). Any apparent VA advantage with contact systems was lost after controlling for confounders (p=0.097).
  • Contact vs. non-contact WAVS for chandelier-assisted scleral buckling showed comparable anatomic and visual outcomes (PMID 38454850).
  • The choice between systems is therefore largely surgeon preference and familiarity rather than a difference in outcomes.

Summary

AspectKey Point
PurposePanoramic retinal view extending to ora serrata
Two main typesContact (better resolution) vs. Non-contact (more flexible, assistant-independent)
Optical mechanismIndirect lens + prism reinversion system below microscope
Best combined withChandelier illumination for bimanual surgery
IndicationsPeripheral retinal surgery, RD repair, PDR, giant tears, scleral buckling
OutcomesContact and non-contact are equivalent in clinical trials

Key References:
  • Kanski's Clinical Ophthalmology, 10th ed., p. 708
  • Inoue M. "Wide-angle viewing system." Dev Ophthalmol. 2014. [PMID 25196756]
  • de Oliveira PR et al. "Vitreoretinal instruments: vitrectomy cutters, endoillumination and wide-angle viewing systems." Int J Retina Vitreous. 2016. [PMID 27980854] (free PMC text)
  • Tieger MG et al. "Contact versus non-contact wide-angle viewing systems - PRO Study." Br J Ophthalmol. 2021. [PMID 32409294]
  • Kelkar AS et al. "Chandelier-assisted scleral buckling - contact vs. non-contact WAVS." Indian J Ophthalmol. 2024. [PMID 38454850]
  • Pan QT et al. "Novel bubble ultra-wide field viewing system." Acta Ophthalmol. 2022. [PMID 34403213]
  • Sadeghi E et al. "Recent developments in surgical vision technologies for vitreoretinal surgery." Expert Rev Med Devices. 2023. [PMID 37394991]

Trans conjunctival vitrectomy

Finding Sources
Finding Sources
Searching PubMed

transconjunctival sutureless vitrectomy microincision MIVS

Reading File
Searching PubMed

25-gauge 27-gauge vitrectomy outcomes complications

Finding Sources
Reading Article

PMID: 35272553

Reading Article

PMID: 38237087

Reading Article

PMID: 19880185

Finding Sources
Searching PubMed

microincision vitrectomy surgery endophthalmitis wound suture complications review

Searching PubMed

23-gauge vitrectomy Fujii introduction transconjunctival

Reading Article

PMID: 25196754

Reading Article

PMID: 38087284

I now have comprehensive information. Let me compile the full response.

Transconjunctival Vitrectomy (Microincision Vitrectomy Surgery - MIVS)

Historical Background

Traditional pars plana vitrectomy (PPV) was introduced by Robert Machemer in 1971 using a 17-gauge (1.5 mm) single-port instrument. The standard system then evolved to 20-gauge (0.9 mm) instrumentation, which required:
  • Conjunctival peritomy (surgical dissection of the conjunctiva)
  • Scleral sutures at each port site at the end of surgery
  • Postoperative subconjunctival scarring, longer recovery, and greater patient discomfort
The drive to minimize surgical trauma led to the development of transconjunctival sutureless microincision vitrectomy surgery (MIVS) - the direct passage of small-gauge trocars through the conjunctiva and sclera without prior conjunctival dissection.
Key milestones:
  • 2002 - Fujii et al. introduced 25-gauge (0.5 mm) transconjunctival sutureless vitrectomy
  • 2005 - Eckardt introduced 23-gauge (0.6 mm) transconjunctival vitrectomy
  • 2010 - Oshima et al. introduced 27-gauge (0.4 mm) transconjunctival MIVS (PMID 19880185)

Gauge Sizes and Dimensions

SystemGaugeShaft DiameterWound SizeEra Introduced
Conventional20G0.9 mm~1.0 mm1970s (standard)
Large MIVS23G0.6 mm~0.7 mm2005
Standard MIVS25G0.5 mm~0.55 mm2002
Ultra-small MIVS27G0.4 mm~0.43 mm2010
In MIVS, the instrumentation has conventionally been 0.9 mm (20-gauge), with 23-gauge, 25-gauge and 27-gauge sutureless systems increasingly becoming the standard of care. - Kanski's Clinical Ophthalmology, p. 708

Principle of Transconjunctival Access

The Trocar-Cannula System

Instead of cutting the conjunctiva and suturing it back, MIVS uses a trocar-cannula assembly:
  1. The conjunctiva is displaced laterally away from the scleral entry site (by 1-2 mm using a cotton-tipped applicator or the trocar tip itself)
  2. A sharp-tipped trocar is inserted through conjunctiva and sclera simultaneously in a single step
  3. The trocar is removed, leaving a self-retaining cannula in place
  4. All surgical instruments (cutter, light pipe, forceps, laser) pass through these cannulas
  5. At the end of surgery, cannulas are removed; the displaced conjunctival wound does not overlie the scleral wound - this misalignment prevents vitreous wick formation
There are three ports:
  • Infusion cannula (usually inferotemporal) - maintains IOP and vitreous cavity volume
  • Vitreous cutter port (usually superotemporal)
  • Light pipe / accessory instrument port (usually superonasal)
All are placed 3.5-4 mm posterior to the limbus (pars plana).

Wound Construction - Critical Technical Points

Wound construction is critical in MIVS. Three key steps (PMID 25196754):
  1. Conjunctival displacement - slide conjunctiva away from the planned scleral entry point before trocar insertion. When the cannula is removed at the end, the conjunctival hole and scleral hole are no longer aligned, preventing a vitreous wick from tracking outward (a major pathway for endophthalmitis)
  2. Scleral flattening on insertion - pressing flat on the sclera during trocar insertion creates a longer wound cord length, which improves self-sealing
  3. Angled (oblique/beveled) incision - inserting the trocar at an angle (at least 30 degrees initially, then directing posteriorly) creates a tunneled, oblique wound that seals better under IOP than a perpendicular incision; angled incisions have been proven to provide superior wound stability

Instrumentation Components

1. Vitreous Cutter

  • Inner guillotine blade oscillating at high speed
  • Speed range: 1,500 cpm (older systems) up to 5,000-7,500 cpm in ultra-high-speed cutters (some newer systems reach 10,000-16,000 cpm)
  • Higher cut rates = smaller vitreous fragments = less traction on the vitreoretinal interface during aspiration
  • 27G cutters historically had lower duty cycles and flow rates (~62% infusion, ~80% aspiration of 25G) but newer designs have substantially closed this gap

2. Infusion Cannula

  • Self-retaining in small-gauge systems
  • Placed 3.5 mm behind limbus in pseudophakic/aphakic eyes, 4 mm in phakic eyes
  • Maintains IOP and volume via balanced salt solution (BSS) or air/gas

3. Illumination (Light Pipe)

  • Fibreoptic probe inserted through a port
  • Initially MIVS had reduced illumination (halogen bulbs were too dim at small gauges)
  • Modern systems use xenon and mercury vapour sources - matching or exceeding 20G illumination levels
  • UV/blue light filtration reduces retinal phototoxicity
  • Chandelier sources (self-retaining) free both hands for bimanual work

4. Accessory Instruments

  • Micro-forceps, scissors, picks, flute needle (for fluid-air exchange), endodiathermy, endolaser probes - all in small-gauge format
  • Smaller-calibre cutters can act as multifunctional instruments, reducing instrument exchanges

Advantages of MIVS Over 20G Vitrectomy

AdvantageDetail
No conjunctival peritomyConjunctiva preserved; less scarring for future filtering surgery if needed
No suturesFaster wound closure, less postoperative irritation
Shorter operating timeEspecially port setup and wound closure
Less surgical traumaReduced postoperative inflammation
Faster visual rehabilitationPatients return to baseline faster
Less postoperative astigmatismSmaller wounds cause less corneal distortion
Reduced subconjunctival scarringImportant for glaucoma patients needing future trabeculectomy
Compatible with bimanual surgeryVia chandelier illumination

Disadvantages and Complications Unique to MIVS

1. Hypotony

  • Self-sealing wounds may leak postoperatively, especially if wound construction is suboptimal
  • Meta-analysis (PMID 35272553, 22 RCTs, n=1,678 eyes): small-gauge PPV was associated with a significantly greater incidence of hypotony (RR = 3.79; 95% CI 2.02-7.10) and choroidal detachment (RR = 5.65) compared to 20G
  • Most cases are transient and resolve without intervention
  • If persistent: suturing the wound at surgery end (which negates the "sutureless" benefit)

2. Wound Suturing Rates

  • Not all small-gauge wounds seal reliably - some require a suture intraoperatively
  • 23G required more frequent port suturing than 25G (RR = 0.46; PMID 35272553)
  • 27G achieves the highest sutureless rate: 96.5% sutureless vs. 91.1% for 25G (PMID 38237087, RCT n=463)

3. Endophthalmitis Risk

  • A theoretical concern with small sutureless ports - early reports suggested higher rates
  • Subsequent larger studies have shown no significantly increased endophthalmitis risk vs. 20G
  • Key protective mechanism: conjunctival displacement creating wound misalignment
  • Kanski's: "Early concerns about an increased risk of postoperative endophthalmitis do not seem to have been borne out"

4. Instrument Flexibility and Flow Rates

  • Very small gauges (27G) have reduced flow rates and aspiration compared to 25G
  • Can prolong surgical time in complex cases (vitreous haemorrhage, PDR with thick membranes)
  • However, in PDR, 27G beveled-tip was actually more efficient at membrane cutting with fewer instrument exchanges and less intraoperative hemorrhage (PMID 38087284, RCT)

5. Limited Use in Complex Cases (historically)

  • Very early MIVS was limited to "simple" cases (macular holes, ERM)
  • Modern high-speed cutters and improved instruments have expanded 25G/27G use to complex PDR, retinal detachment, and pediatric cases

Gauge Comparison: 23G vs 25G vs 27G

Feature23G25G27G
Wound diameter0.6 mm0.5 mm0.4 mm
Sutureless rateLower (often needs suture)~91%~96.5%
Flow rateHighest of the 3IntermediateLowest
Best forComplex retinal detachment, complex PDRVersatile - most indicationsMacular surgery, less complex cases
Surgery time vs 25GSimilarReferenceSimilar (slight increase possible)
Visual outcomes vs 25GSimilarReferenceSimilar or slightly better (PMID 35272553: -0.06 logMAR)
Hypotony riskHigher than 25GIntermediateLower (better self-sealing)

Current Clinical Evidence

Meta-Analysis of RCTs (PMID 35272553 - Chaban et al., 2022, 22 RCTs, n=1,678 eyes)

  • No significant difference in BCVA between 20G and small-gauge PPV
  • Small-gauge had higher hypotony (RR 3.79) and choroidal detachment (RR 5.65)
  • 23G required more suturing than 25G
  • 27G may achieve better final BCVA than 25G (WMD -0.06 logMAR) but requires longer surgery (+4 min)

Large RCT: 25G vs 27G (PMID 38237087 - Benzerroug et al., 2024, n=463 eyes)

  • No significant difference in surgery time, BCVA, macular thickness, or complication rates
  • 27G achieved a significantly higher sutureless rate (96.5% vs 91.1%, p=0.017)
  • 27G is now considered fully equivalent and has advantages in wound sealing

27G in PDR (PMID 38087284 - RCT, 2023)

  • 27G beveled-tip was more efficient at membrane cutting in PDR
  • Fewer instrument exchanges, less intraoperative hemorrhage
  • Equal total operating time; fewer wound sutures needed

Indications (Modern MIVS)

IndicationPreferred Gauge
Macular hole25G or 27G
Epiretinal membrane25G or 27G
Vitreomacular traction25G or 27G
Vitreous haemorrhage (simple)25G or 27G
Vitreous biopsy (uveitis/lymphoma)25G or 27G
Retinal detachment (non-complex)25G or 23G
Complex retinal detachment / PVR23G or 25G
Proliferative diabetic retinopathy25G or 27G (increasingly)
Pediatric vitrectomy25G or 27G
Dense vitreous haemorrhage23G or 25G

Summary

Transconjunctival (MIVS) vitrectomy has largely replaced 20-gauge surgery as the standard of care worldwide. Key principles:
  • Conjunctival displacement + angled tunneled wound = self-sealing without sutures
  • 25G and 27G are now the dominant platforms - equivalent outcomes with high sutureless rates
  • 27G offers the best wound security (highest sutureless rate) and may be slightly superior for macular surgery visual outcomes
  • Residual trade-off: higher hypotony and choroidal detachment risk vs. 20G, but these are usually transient
  • Ongoing innovation continues to expand the complexity of cases manageable through the smallest gauges

Key References:
  • Kanski's Clinical Ophthalmology, 10th ed., p. 708
  • Oshima Y et al. "27-gauge MIVS system." Ophthalmology. 2010. [PMID 19880185]
  • Trichonas G, Kaiser PK. "Wound construction." Dev Ophthalmol. 2014. [PMID 25196754]
  • Chaban YV et al. "PPV port sizes: meta-analysis of RCTs." Ophthalmic Surg Lasers. 2022. [PMID 35272553]
  • Benzerroug M et al. "25G vs 27G vitrectomy - large RCT." Retina. 2024. [PMID 38237087]
  • Liu J et al. "27G beveled vs 25G flat-tip MIVS in PDR - RCT." BMC Ophthalmol. 2023. [PMID 38087284]
This is a shared conversation. Sign in to Orris to start your own chat.